Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Real-world effectiveness and corticosteroid-sparing effects of belumosudil in chronic gvhd: A multi-database analysis

Aleksandr Lazaryan, Kevin Hall, Aaron Logan, Edmund Waller, Eric Gaskill, Shaum Kabadi, Alyshah Abdul Sultan, Ekaterina Ponomareva, Catherine Lee

Blood (2025) 146 (Supplement 1): 7765.

https://doi.org/10.1182/blood-2025-7765

Published: 2025

Journal Articles

High incidence of impaired graft function after allogeneic HSCT for myelofibrosis, and successful utilization of stem cell boost

Maria Leon-Camarena, Leah Philips, Joseph Rimando, Colin Vale, Anthony Hunter, Michael Hochman, Amelia Langston, William Blum, Edmund Waller

Blood (2025) 146 (Supplement 1): 6394.

https://doi.org/10.1182/blood-2025-6394

Published: 2025

Journal Articles

Preliminary safety and efficacy of myeloablative orca-q with tacrolimus or without graft-versus-host disease prophylaxis for treatment of advanced hematologic malignancies

Samer Srour, Mehrdad Abedi, Amandeep Salhotra, Edmund Waller, Hannah Choe, Anna Pavlova, Tamara Zharkevich, Scott Killian, J. Scott McClellan, Nate Fernhoff, Robert Lowsky

Blood (2025) 146 (Supplement 1): 932.

https://doi.org/10.1182/blood-2025-932

Published: 2025

Journal Articles

VIP, a novel phagocytosis checkpoint in TP53-mutated Acute Myeloid Leukemia

Zihan Chen, Fanyuan Zeng, Jian-Ming Li, Cynthia Giver, Kiranj Chaudagar, Edmund Waller

Blood (2025) 146 (Supplement 1): 3495.

https://doi.org/10.1182/blood-2025-3495

Published: 2025

Journal Articles

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Colleen Kelly, Morgan Paul, Wendy London, Rahela Aziz-Bose, Puja Umaretiya, Erica Esrick, Victoria Coleman-Cowger, Gary Schiller, Mehrdad Abedi, Joseph Antin, Mary Horowitz, Neena Kapoor, Edmund Waller, Sonali Chaudhury, Mary Eapen, Mark Walters, David Williams, Kira Bona

Blood (2025) 146 (Supplement 1): 6224.

https://doi.org/10.1182/blood-2025-6224

Published: 2025

Journal Articles

MO-TRANS update: A randomized, double-blind, placebo-controlled, multi-center phase III study of mocravimod (MOC) as maintenance treatment in AML patients undergoing allogeneic hematopoietic cell transplantation

Marcos de Lima, Gabriela Sanchez-Petitto, Edmund Waller, Charles Craddock, Maria Calbacho, Giancarlo Fatobene, Daniel Ghali, Jennifer Rubel, Stephan Oehen, Jens Hasskarl

Blood (2025) 146 (Supplement 1): 6086.

https://doi.org/10.1182/blood-2025-6086

Published: 2025

Journal Articles

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Blood (2025) 146 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2025-1058

Published: 2025

Journal Articles

Genetic deletion of vasoactive intestinal peptide (VIP) and PI3K signaling pathways impair CAR T cell function

YuJie Chen, Ronald Roberts, Dejah Blake, Shuhua Wang, Heather Lin, Shayna Jankowski, Jian-ming Li, Tuisha Gupta, Isabella Lin, Kiranj Chaudagar, Sarwish Rafiq, Edmund Waller

Blood (2025) 146 (Supplement 1): 7633.

https://doi.org/10.1182/blood-2025-7633

Published: 2025

Journal Articles

Real-world effectiveness of belumosudil for chronic GVHD by line of treatment: Analysis of academic and community practice patterns

Aleksandr Lazaryan, Kevin Hall, Catherine Lee, Edmund Waller, Rebecca Gonzalez, Shaum Kabadi, Alyshah Abdul Sultan, Ekaterina Ponomareva, Aaron Logan

Blood (2025) 146 (Supplement 1): 7771.

https://doi.org/10.1182/blood-2025-7771

Published: 2025

Journal Articles

Azer-cel, an allogeneic (allo) CD19 CAR T, in combination with low-dose interleukin-2 (IL-2) demonstrates clinical activity in patients with large B-cell lymphoma (LBCL) who relapsed after autologous (auto) CAR T

Supriya Gupta, Edmund Waller, Ran Reshef, Vinay Vanguru, Adam Olszewski, Scott Solomon, Joseph Maakaron, Aparna Raval, Sharon Yavrom, John Byon, Bijal Shah

Blood (2025) 146 (Supplement 1): 267.

https://doi.org/10.1182/blood-2025-267

Published: 2025

Journal Articles

Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a

Blood (2025) 146 (Supplement 1): 6094.

https://doi.org/10.1182/blood-2025-6094

Published: 2025

Journal Articles

A VPAC1/2-targeted antagonist, preferentially binds to activated T cells and enhances T cell activation

Sonia Mecorapaj, Yuou Wang, Srijon Sarkar, Edmund Waller

Blood (2025) 146 (Supplement 1): 2553.

https://doi.org/10.1182/blood-2025-2553

Published: 2025

Journal Articles

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

Blood (2025) 146 (Supplement 1): 170.

https://doi.org/10.1182/blood-2025-170

Published: 2025

Journal Articles

A chronotherapeutic approach to VIP receptor antagonist (ANT308) in anti-tumor activity

Isabella Lin, Shayna Jankowski, Edmund Waller

Blood (2025) 146 (Supplement 1): 3011.

https://doi.org/10.1182/blood-2025-3011

Published: 2025

Journal Articles

Orca-T improves chronic graph-versus-host disease free in patients with a broad range of demographic and clinical variables: Results of randomized, Phase 3 trial

Blood (2025) 146 (Supplement 1): 2477.

https://doi.org/10.1182/blood-2025-2477

Published: 2025

Journal Articles

Simultaneous PD-1 and VIP receptor blockade optimizes tumor immunotherapy in P815 Acute Myeloid Leukemia model

Stella Lee, Jian-Ming Li, Edmund Waller

Blood (2025) 146 (Supplement 1): 2546.

https://doi.org/10.1182/blood-2025-2546

Published: 2025

Journal Articles

VIP pathway inhibition alters microbial metabolism to balance graft-versus-leukemia and gvhd

Kayla Robinson, Shayna Jankowski, Jian-Ming Li, Edmund Waller

Blood (2025) 146 (Supplement 1): 6034.

https://doi.org/10.1182/blood-2025-6034

Published: 2025

Journal Articles

Observational comparison of orca-T to registry-based post-transplant cyclophosphamide patients using matched unrelated donors

Blood (2025) 146 (Supplement 1): 6029.

https://doi.org/10.1182/blood-2025-6029

Published: 2025

Journal Articles

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Hongzheng Zhang, Michael Graiser, Donald Hutcherson, M. Olufemi Dada, Stephanie McMillan, BSN, RN, OCN, Ali Zahir, Christopher R Flowers, MD, MS, Edmund Waller

Blood (2010) 116 (21): 1359.

https://doi.org/10.1182/blood.V116.21.1359.1359

Published: 2010

Journal Articles

Cost-Effectiveness Analysis of a “Just-In-Time” Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant

Jie Li, Ellie Hamilton, Louette Vaughn, Michael Graiser, Heather Renfroe, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Christopher R Flowers, MD, MS, Mary Jo Lechowicz, MD, Amelia Langston, MD, Darlene Anderson, Edmund Waller, MD, PhD

Blood (2010) 116 (21): 2246.

https://doi.org/10.1182/blood.V116.21.2246.2246

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world effectiveness and corticosteroid-sparing effects of belumosudil in chronic gvhd: A multi-database analysis

High incidence of impaired graft function after allogeneic HSCT for myelofibrosis, and successful utilization of stem cell boost

Preliminary safety and efficacy of myeloablative orca-q with tacrolimus or without graft-versus-host disease prophylaxis for treatment of advanced hematologic malignancies

VIP, a novel phagocytosis checkpoint in TP53-mutated Acute Myeloid Leukemia

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

MO-TRANS update: A randomized, double-blind, placebo-controlled, multi-center phase III study of mocravimod (MOC) as maintenance treatment in AML patients undergoing allogeneic hematopoietic cell transplantation

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Genetic deletion of vasoactive intestinal peptide (VIP) and PI3K signaling pathways impair CAR T cell function

Real-world effectiveness of belumosudil for chronic GVHD by line of treatment: Analysis of academic and community practice patterns

Azer-cel, an allogeneic (allo) CD19 CAR T, in combination with low-dose interleukin-2 (IL-2) demonstrates clinical activity in patients with large B-cell lymphoma (LBCL) who relapsed after autologous (auto) CAR T

Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a

A VPAC1/2-targeted antagonist, preferentially binds to activated T cells and enhances T cell activation

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

A chronotherapeutic approach to VIP receptor antagonist (ANT308) in anti-tumor activity

Orca-T improves chronic graph-versus-host disease free in patients with a broad range of demographic and clinical variables: Results of randomized, Phase 3 trial

Simultaneous PD-1 and VIP receptor blockade optimizes tumor immunotherapy in P815 Acute Myeloid Leukemia model

VIP pathway inhibition alters microbial metabolism to balance graft-versus-leukemia and gvhd

Observational comparison of orca-T to registry-based post-transplant cyclophosphamide patients using matched unrelated donors

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Cost-Effectiveness Analysis of a “Just-In-Time” Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only